Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
An Exposure-Based Implementation Strategy to Decrease Clinician Anxiety About Delivering Suicide Prevention Evidence-Based Practices
This study has finished and is no longer accepting participants.
In PhiladelphiaThis study has finished and is no longer accepting participants.
In San Francisco
An Extended-Release Form of Clonidine as an Anti-Manic Agent: An Add-On, Open-Label Study
This study ended early.
Location not clearly listedAn Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
Read the official source — NCT01895452Researchers compared ALKS 9072, Low Dose and ALKS 9072, High Dose, tracking side effects to assess long-term safety in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little Rock
An Open-label Extension Trial of Individualized Repetitive Transcranial Magnetic Stimulation in Patients With Auditory Verbal Hallucinations Who Completed Protocol #8116
This study ended early.
In New YorkA Single-Arm, Open Label, 16-week Extension Study to Evaluate the Efficacy and Safety of a Second Course of a Digital Therapeutic as an Adjunct to Standard of Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
In New YorkResearchers studied SEP-363856, tracking side effects to assess safety and tolerability in adults with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers studied SEP-363856, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimAn Open-label Extension Study to Assess the Long-term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixAn Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Subjects With DSM-5 Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Bentonville
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
Read the official source — NCT00345943An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
This study has finished and is no longer accepting participants.
In New YorkImaging Stimulant vs. Non-Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
This study ended early.
In New YorkWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.